NovoCure's METIS phase 3 trial data in brain metastases to be presented at ASCO 2024

NovoCure Ltd

Abstract for METIS phase 3 trial in brain metastases from NSCLC available May 23 on ASCO website.
Oral presentation scheduled for June 3 at 10:24 AM CDT during CNS Tumors session.
No data disclosed yet; trial results are pending presentation at ASCO.

item 7.01 item 9.01

NovoCure Ltd filing history →

Source: SEC EDGAR

accession 0001645113-24-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.